DHEA 15

Name: DHEA 15
Brand: Allergy Research Group

BrandAllergy Research Group→Non-Nutrient/Non-Botanical Tablet or Pill 7 ingredients 1 banned 1 caution DSLD #54365

Net contents: 60 scored tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2015-12-23

2 Ingredients (7)

IngredientGroupSafety

DehydroepiandrosteroneDHEABanned in ≥1 country

Microcrystalline CelluloseCellulose—

MicosolleTBD—

Vegetable OilVegetable Oil (unspecified)—

Vegetable WaxBlend (Combination)—

Cab-o-silFumed Silica—

Magnesium StearateMagnesiumUse with Caution

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⛔ Contains an ingredient banned in ≥1 country

DHEA 🇨🇦 🇬🇧 🇪🇺 🇦🇺 — Not approved for OTC sale as supplement.

⚠️ Use with caution — restricted in some markets

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

DHEA — Banned in ≥1 country

⚠ Hormonal: acne, hirsutism, voice deepening

⚠ May promote hormone-sensitive cancers

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

4 Label claims

• All Other

5 Data source

DSLD ID54365

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2015-12-23

6 More from Allergy Research Group

View Allergy Research Group Safety Scorecard → 76 products

Acetyl-Glutathione 300 mg Adrenal Cortex Aller-Aid Formula II Ammonium Chloride Buffered Brain Beef Natural Glandular BrainWave Plus

7 Cite this page

Vancouver

Pkhakadze G. DHEA 15 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/dhea-15-54365/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG